SARAN ATUL
SEC CIK 1591070 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | EVP, GC, Corp Dev, Sec | 86.6K | — | — | 9 | 2022-02-22 | 2023-02-28 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
SARAN ATUL made no open-market trades at EBS in the last 12 months.
Transactions 9
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-02-28 | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, Chief Strat, Dev Off | F - Tax | $12.38 | -971 | 86.6K | -1% | -$12.0K | |
| M | 2023-02-27 | 2023-02-23+ | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, Chief Strat, Dev Off | F - Tax | $13.89 | -1,210 | 88.5K | -1% | -$16.8K |
| 2023-02-10 | 2023-02-08 | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, Chief Strat, Dev Off | A - Grant | $0.00 | +95 | 90.9K | +0.1% | $0 | |
| 2023-02-10 | 2023-02-08 | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, Chief Strat, Dev Off | F - Tax | $13.25 | -2,051 | 88.8K | -2% | -$27.2K | |
| DM | 2022-03-02 | 2022-03-01 | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, Chief Strat, Dev Off | A - Grant | $0.00 | +48.3K | 91.5K | +112% | $0 |
| D | 2022-03-02 | 2022-02-28 | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, Chief Strat, Dev Off | F - Tax | $39.64 | -764 | 90.8K | -0.8% | -$30.3K |
| M | 2022-02-25 | 2022-02-23+ | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, GC, Corp Dev, Sec | F - Tax | $42.39 | -1,299 | 43.2K | -3% | -$55.1K |
| 2022-02-24 | 2022-02-22 | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, GC, Corp Dev, Sec | F - Tax | $42.23 | -2,084 | 44.5K | -4% | -$88.0K | |
| 2022-02-24 | 2022-02-22 | EBS | Emergent BioSolutions Inc. | SARAN ATUL | EVP, GC, Corp Dev, Sec | A - Grant | $0.00 | +1,836 | 46.6K | +4% | $0 |
Purchase Sale Sale after option exercise All abbreviations